25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Collegium Pharmaceutical Inc
Buy, Hold or Sell?

Let's analyze Collegium Pharmaceutical Inc together

I guess you are interested in Collegium Pharmaceutical Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Collegium Pharmaceutical Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Collegium Pharmaceutical Inc

I send you an email if I find something interesting about Collegium Pharmaceutical Inc.

1. Quick Overview

1.1. Quick analysis of Collegium Pharmaceutical Inc (30 sec.)










1.2. What can you expect buying and holding a share of Collegium Pharmaceutical Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€7.02
Expected worth in 1 year
€8.80
How sure are you?
53.8%

+ What do you gain per year?

Total Gains per Share
€1.78
Return On Investment
6.0%

For what price can you sell your share?

Current Price per Share
€29.60
Expected price per share
€27.40 - €32.80
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Collegium Pharmaceutical Inc (5 min.)




Live pricePrice per Share (EOD)
€29.60
Intrinsic Value Per Share
€5.24 - €3.96
Total Value Per Share
€12.26 - €10.98

2.2. Growth of Collegium Pharmaceutical Inc (5 min.)




Is Collegium Pharmaceutical Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$234.2m$188.5m$28.5m13.2%

How much money is Collegium Pharmaceutical Inc making?

Current yearPrevious yearGrowGrow %
Making money$22.1m$2.2m$19.8m89.8%
Net Profit Margin15.0%1.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Collegium Pharmaceutical Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Collegium Pharmaceutical Inc?

Welcome investor! Collegium Pharmaceutical Inc's management wants to use your money to grow the business. In return you get a share of Collegium Pharmaceutical Inc.

First you should know what it really means to hold a share of Collegium Pharmaceutical Inc. And how you can make/lose money.

Speculation

The Price per Share of Collegium Pharmaceutical Inc is €29.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Collegium Pharmaceutical Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Collegium Pharmaceutical Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €7.02. Based on the TTM, the Book Value Change Per Share is €0.45 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Collegium Pharmaceutical Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.291.0%0.682.3%0.291.0%0.301.0%0.180.6%
Usd Book Value Change Per Share0.551.8%0.461.6%-0.11-0.4%0.230.8%0.280.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.551.8%0.461.6%-0.11-0.4%0.230.8%0.280.9%
Usd Price Per Share35.32-33.36-21.82-21.70-19.94-
Price to Earnings Ratio30.57-15.49-2.89-31.80-22.46-
Price-to-Total Gains Ratio64.51--44.85--82.76-10.78--31.23-
Price to Book Ratio4.87-4.97-3.95-3.92-4.28-
Price-to-Total Gains Ratio64.51--44.85--82.76-10.78--31.23-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share30.57088
Number of shares32
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.460.23
Usd Total Gains Per Share0.460.23
Gains per Quarter (32 shares)14.717.42
Gains per Year (32 shares)58.8329.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10594903020
2011810805950
3017616708980
402352260119110
502942850148140
603533440178170
704124030208200
804714620237230
905295210267260
1005885800297290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%8.04.00.066.7%15.05.00.075.0%16.010.00.061.5%16.010.00.061.5%
Book Value Change Per Share3.01.00.075.0%6.06.00.050.0%12.08.00.060.0%14.012.00.053.8%14.012.00.053.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.026.00.0%0.00.026.00.0%
Total Gains per Share3.01.00.075.0%6.06.00.050.0%12.08.00.060.0%14.012.00.053.8%14.012.00.053.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Collegium Pharmaceutical Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5300.445+19%-0.104+120%0.224+136%0.270+96%
Book Value Per Share--7.0186.488+8%5.366+31%5.479+28%4.794+46%
Current Ratio--0.9661.113-13%1.142-15%1.127-14%1.120-14%
Debt To Asset Ratio--0.8570.820+4%0.842+2%0.781+10%0.777+10%
Debt To Equity Ratio--5.9804.677+28%5.353+12%3.960+51%4.007+49%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value---250997641.60060019961.550-518%-255856465.650+2%-30024006.870-88%3489909.300-7292%
Eps--0.2800.662-58%0.282-1%0.294-5%0.178+57%
Ev To Ebitda Ratio--infnannan%infnan%nannan%nannan%
Ev To Sales Ratio---0.4070.117-447%-0.484+19%0.043-1039%0.125-425%
Free Cash Flow Per Share---0.2771.437-119%1.899-115%0.521-153%0.521-153%
Free Cash Flow To Equity Per Share--4.1880.788+431%0.383+995%1.053+298%1.053+298%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.964--------
Intrinsic Value_10Y_min--5.237--------
Intrinsic Value_1Y_max--4.626--------
Intrinsic Value_1Y_min--4.546--------
Intrinsic Value_3Y_max--10.676--------
Intrinsic Value_3Y_min--10.258--------
Intrinsic Value_5Y_max--12.842--------
Intrinsic Value_5Y_min--12.197--------
Market Cap954605920.000-16%1105329533.4001047012239.450+6%718556231.700+54%708436898.180+56%646368416.000+71%
Net Profit Margin--0.0590.150-61%0.018+230%0.052+14%0.018+228%
Operating Margin----0%0.066-100%0.079-100%0.052-100%
Operating Ratio--1.1741.051+12%1.274-8%1.352-13%1.427-18%
Pb Ratio4.218-16%4.8734.973-2%3.950+23%3.922+24%4.277+14%
Pe Ratio26.462-16%30.57415.488+97%2.888+958%31.804-4%22.463+36%
Price Per Share29.600-16%34.20032.300+6%21.125+62%21.010+63%19.306+77%
Price To Free Cash Flow Ratio-26.725+13%-30.878-4.717-85%3.559-968%1.967-1670%1.513-2141%
Price To Total Gains Ratio55.836-16%64.514-44.855+170%-82.763+228%10.780+498%-31.229+148%
Quick Ratio--0.6740.606+11%0.457+47%0.454+48%0.433+55%
Return On Assets--0.0060.019-70%0.002+194%0.010-45%0.005+20%
Return On Equity--0.0400.105-62%0.012+245%0.040+0%0.010+293%
Total Gains Per Share--0.5300.445+19%-0.104+120%0.224+136%0.270+96%
Usd Book Value--234268916.632217106155.349+8%188555134.238+24%191676699.880+22%166730362.078+41%
Usd Book Value Change Per Share--0.5480.460+19%-0.107+120%0.232+136%0.279+96%
Usd Book Value Per Share--7.2496.700+8%5.542+31%5.659+28%4.951+46%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value---259230364.24461988616.289-518%-264248557.723+2%-31008794.295-88%3604378.325-7292%
Usd Eps--0.2890.683-58%0.291-1%0.303-5%0.184+57%
Usd Free Cash Flow---9242602.18148104929.475-119%66621882.471-114%16895922.768-155%12996863.668-171%
Usd Free Cash Flow Per Share---0.2861.484-119%1.961-115%0.538-153%0.538-153%
Usd Free Cash Flow To Equity Per Share--4.3250.814+431%0.395+995%1.088+298%1.088+298%
Usd Market Cap985916994.176-16%1141584342.0961081354240.904+6%742124876.100+54%731673628.440+56%667569300.045+71%
Usd Price Per Share30.571-16%35.32233.359+6%21.818+62%21.699+63%19.939+77%
Usd Profit--9334598.22222147546.729-58%2253902.988+314%8793371.517+6%5187392.110+80%
Usd Revenue--159294143.685149804802.124+6%136654618.132+17%107059741.950+49%99243766.826+61%
Usd Total Gains Per Share--0.5480.460+19%-0.107+120%0.232+136%0.279+96%
 EOD+3 -5MRQTTM+17 -18YOY+24 -125Y+21 -1510Y+23 -13

3.3 Fundamental Score

Let's check the fundamental score of Collegium Pharmaceutical Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1526.462
Price to Book Ratio (EOD)Between0-14.218
Net Profit Margin (MRQ)Greater than00.059
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.674
Current Ratio (MRQ)Greater than10.966
Debt to Asset Ratio (MRQ)Less than10.857
Debt to Equity Ratio (MRQ)Less than15.980
Return on Equity (MRQ)Greater than0.150.040
Return on Assets (MRQ)Greater than0.050.006
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Collegium Pharmaceutical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.018
Ma 20Greater thanMa 5031.400
Ma 50Greater thanMa 10029.872
Ma 100Greater thanMa 20031.322
OpenGreater thanClose29.600
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Fundamental data was last updated by Penke on 2025-02-01 00:36:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Collegium Pharmaceutical Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Collegium Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 5.9% means that €0.06 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Collegium Pharmaceutical Inc:

  • The MRQ is 5.9%. The company is making a profit. +1
  • The TTM is 15.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ5.9%TTM15.0%-9.1%
TTM15.0%YOY1.8%+13.2%
TTM15.0%5Y5.2%+9.8%
5Y5.2%10Y1.8%+3.4%
4.3.1.2. Return on Assets

Shows how efficient Collegium Pharmaceutical Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Collegium Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.6% Return on Assets means that Collegium Pharmaceutical Inc generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Collegium Pharmaceutical Inc:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.6%TTM1.9%-1.4%
TTM1.9%YOY0.2%+1.7%
TTM1.9%5Y1.0%+0.9%
5Y1.0%10Y0.5%+0.6%
4.3.1.3. Return on Equity

Shows how efficient Collegium Pharmaceutical Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Collegium Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.0% Return on Equity means Collegium Pharmaceutical Inc generated €0.04 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Collegium Pharmaceutical Inc:

  • The MRQ is 4.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 10.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.0%TTM10.5%-6.5%
TTM10.5%YOY1.2%+9.3%
TTM10.5%5Y4.0%+6.5%
5Y4.0%10Y1.0%+3.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Collegium Pharmaceutical Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Collegium Pharmaceutical Inc is operating .

  • Measures how much profit Collegium Pharmaceutical Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Collegium Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Collegium Pharmaceutical Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY6.6%-6.6%
TTM-5Y7.9%-7.9%
5Y7.9%10Y5.2%+2.7%
4.3.2.2. Operating Ratio

Measures how efficient Collegium Pharmaceutical Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.17 means that the operating costs are €1.17 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Collegium Pharmaceutical Inc:

  • The MRQ is 1.174. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.051. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.174TTM1.051+0.122
TTM1.051YOY1.274-0.223
TTM1.0515Y1.352-0.301
5Y1.35210Y1.427-0.074
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Collegium Pharmaceutical Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Collegium Pharmaceutical Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.97 means the company has €0.97 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Collegium Pharmaceutical Inc:

  • The MRQ is 0.966. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.113. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.966TTM1.113-0.147
TTM1.113YOY1.142-0.028
TTM1.1135Y1.127-0.014
5Y1.12710Y1.120+0.007
4.4.3.2. Quick Ratio

Measures if Collegium Pharmaceutical Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Collegium Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.67 means the company can pay off €0.67 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Collegium Pharmaceutical Inc:

  • The MRQ is 0.674. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.606. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.674TTM0.606+0.067
TTM0.606YOY0.457+0.150
TTM0.6065Y0.454+0.153
5Y0.45410Y0.433+0.020
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Collegium Pharmaceutical Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Collegium Pharmaceutical Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Collegium Pharmaceutical Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.86 means that Collegium Pharmaceutical Inc assets are financed with 85.7% credit (debt) and the remaining percentage (100% - 85.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Collegium Pharmaceutical Inc:

  • The MRQ is 0.857. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.820. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.857TTM0.820+0.037
TTM0.820YOY0.842-0.022
TTM0.8205Y0.781+0.039
5Y0.78110Y0.777+0.003
4.5.4.2. Debt to Equity Ratio

Measures if Collegium Pharmaceutical Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Collegium Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 598.0% means that company has €5.98 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Collegium Pharmaceutical Inc:

  • The MRQ is 5.980. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.677. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ5.980TTM4.677+1.302
TTM4.677YOY5.353-0.676
TTM4.6775Y3.960+0.717
5Y3.96010Y4.007-0.047
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Collegium Pharmaceutical Inc generates.

  • Above 15 is considered overpriced but always compare Collegium Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 30.57 means the investor is paying €30.57 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Collegium Pharmaceutical Inc:

  • The EOD is 26.462. Based on the earnings, the company is overpriced. -1
  • The MRQ is 30.574. Based on the earnings, the company is overpriced. -1
  • The TTM is 15.488. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD26.462MRQ30.574-4.112
MRQ30.574TTM15.488+15.086
TTM15.488YOY2.888+12.599
TTM15.4885Y31.804-16.316
5Y31.80410Y22.463+9.341
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Collegium Pharmaceutical Inc:

  • The EOD is -26.725. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -30.878. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.717. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-26.725MRQ-30.878+4.153
MRQ-30.878TTM-4.717-26.161
TTM-4.717YOY3.559-8.276
TTM-4.7175Y1.967-6.684
5Y1.96710Y1.513+0.454
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Collegium Pharmaceutical Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 4.87 means the investor is paying €4.87 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Collegium Pharmaceutical Inc:

  • The EOD is 4.218. Based on the equity, the company is fair priced.
  • The MRQ is 4.873. Based on the equity, the company is fair priced.
  • The TTM is 4.973. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.218MRQ4.873-0.655
MRQ4.873TTM4.973-0.100
TTM4.973YOY3.950+1.023
TTM4.9735Y3.922+1.051
5Y3.92210Y4.277-0.355
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Net Working Capital  70,1696,98277,15112,72189,872-42,93346,939-62,059-15,119



6.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,635,154
Total Liabilities1,400,875
Total Stockholder Equity234,279
 As reported
Total Liabilities 1,400,875
Total Stockholder Equity+ 234,279
Total Assets = 1,635,154

Assets

Total Assets1,635,154
Total Current Assets443,810
Long-term Assets1,191,344
Total Current Assets
Cash And Cash Equivalents 38,960
Short-term Investments 80,997
Net Receivables 228,456
Inventory 38,032
Other Current Assets 32,365
Total Current Assets  (as reported)443,810
Total Current Assets  (calculated)418,810
+/- 25,000
Long-term Assets
Property Plant Equipment 20,783
Goodwill 145,959
Intangible Assets 946,875
Long-term Assets Other 5,218
Long-term Assets  (as reported)1,191,344
Long-term Assets  (calculated)1,118,835
+/- 72,509

Liabilities & Shareholders' Equity

Total Current Liabilities459,426
Long-term Liabilities941,449
Total Stockholder Equity234,279
Total Current Liabilities
Short Long Term Debt 64,583
Accounts payable 3,142
Other Current Liabilities 3,044
Total Current Liabilities  (as reported)459,426
Total Current Liabilities  (calculated)70,769
+/- 388,657
Long-term Liabilities
Long term Debt 802,627
Capital Lease Obligations Min Short Term Debt7,185
Long-term Liabilities Other 4,096
Long-term Liabilities  (as reported)941,449
Long-term Liabilities  (calculated)813,908
+/- 127,541
Total Stockholder Equity
Total Stockholder Equity (as reported)234,279
Total Stockholder Equity (calculated)0
+/- 234,279
Other
Capital Stock40
Common Stock Shares Outstanding 32,320
Net Debt 828,250
Net Invested Capital 1,101,489
Net Working Capital -15,616
Property Plant and Equipment Gross 20,783



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
> Total Assets 
673,329
646,508
291,245
294,362
301,581
303,978
306,302
634,793
646,870
643,843
643,841
646,065
713,735
741,803
692,077
1,246,141
1,245,574
1,200,940
1,174,131
1,214,299
1,213,912
1,177,578
1,143,308
1,114,250
1,053,388
1,635,154
1,635,1541,053,3881,114,2501,143,3081,177,5781,213,9121,214,2991,174,1311,200,9401,245,5741,246,141692,077741,803713,735646,065643,841643,843646,870634,793306,302303,978301,581294,362291,245646,508673,329
   > Total Current Assets 
216,293
218,977
237,512
233,843
244,563
249,785
255,720
223,675
250,813
262,132
277,888
296,311
318,532
363,238
315,543
363,638
409,774
405,216
419,989
498,300
537,297
537,086
537,600
539,260
510,198
443,810
443,810510,198539,260537,600537,086537,297498,300419,989405,216409,774363,638315,543363,238318,532296,311277,888262,132250,813223,675255,720249,785244,563233,843237,512218,977216,293
       Cash And Cash Equivalents 
133,747
139,790
146,633
134,910
148,713
153,838
170,019
116,178
145,678
165,423
174,116
182,790
202,771
193,241
186,426
106,698
122,722
134,126
173,688
269,480
283,749
258,532
238,947
228,610
172,894
38,960
38,960172,894228,610238,947258,532283,749269,480173,688134,126122,722106,698186,426193,241202,771182,790174,116165,423145,678116,178170,019153,838148,713134,910146,633139,790133,747
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41,721
46,033
71,601
89,438
98,737
80,997
80,99798,73789,43871,60146,03341,72100000000000000000000
       Net Receivables 
68,380
66,533
77,946
85,139
81,279
84,380
72,953
85,427
81,195
76,466
83,320
93,156
90,098
148,999
105,844
166,345
197,505
195,402
183,119
179,127
167,479
181,851
179,525
174,693
183,855
228,456
228,456183,855174,693179,525181,851167,479179,127183,119195,402197,505166,345105,844148,99990,09893,15683,32076,46681,19585,42772,95384,38081,27985,13977,94666,53368,380
       Inventory 
8,544
9,229
7,817
8,741
9,953
8,760
9,643
15,963
18,815
17,146
15,614
15,498
19,595
17,358
17,394
80,146
77,769
64,652
46,501
32,895
26,026
34,125
32,332
31,276
27,862
38,032
38,03227,86231,27632,33234,12526,02632,89546,50164,65277,76980,14617,39417,35819,59515,49815,61417,14618,81515,9639,6438,7609,9538,7417,8179,2298,544
   > Long-term Assets 
0
0
0
60,519
57,018
54,193
50,582
411,118
396,057
381,711
365,953
349,754
395,203
378,565
376,534
882,503
835,800
795,724
754,142
715,999
676,615
640,492
605,708
574,990
543,190
1,191,344
1,191,344543,190574,990605,708640,492676,615715,999754,142795,724835,800882,503376,534378,565395,203349,754365,953381,711396,057411,11850,58254,19357,01860,519000
       Property Plant Equipment 
3,203
6,039
9,274
19,728
19,941
20,798
20,901
22,018
23,853
26,318
27,379
27,969
27,578
27,464
27,135
28,014
27,222
26,805
26,382
25,537
24,492
22,888
22,012
21,270
20,568
20,783
20,78320,56821,27022,01222,88824,49225,53726,38226,80527,22228,01427,13527,46427,57827,96927,37926,31823,85322,01820,90120,79819,94119,7289,2746,0393,203
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
131,512
130,094
130,094
133,695
133,857
133,857
133,857
133,857
133,857
133,857
145,959
145,959133,857133,857133,857133,857133,857133,857133,695130,094130,094131,512000000000000000
       Intangible Assets 
453,694
421,287
44,255
40,567
36,879
33,191
29,503
386,289
369,494
352,699
335,904
319,109
302,314
285,518
268,723
694,799
647,299
609,747
567,468
530,002
492,539
456,222
421,708
387,191
352,676
946,875
946,875352,676387,191421,708456,222492,539530,002567,468609,747647,299694,799268,723285,518302,314319,109335,904352,699369,494386,28929,50333,19136,87940,56744,255421,287453,694
       Long-term Assets Other 
0
0
0
224
198
204
178
2,811
2,710
2,694
2,670
2,676
2,662
2,557
2,634
2,624
2,614
2,604
2,647
2,634
1,121
1,787
1,872
2,001
1,905
5,218
5,2181,9052,0011,8721,7871,1212,6342,6472,6042,6142,6242,6342,5572,6622,6762,6702,6942,7102,811178204198224000
> Total Liabilities 
590,648
575,728
199,660
208,012
215,758
219,720
218,870
493,730
491,103
471,157
457,810
476,030
460,669
490,709
489,149
1,050,065
1,047,962
1,003,746
979,289
1,034,566
1,013,107
998,705
947,877
892,081
836,805
1,400,875
1,400,875836,805892,081947,877998,7051,013,1071,034,566979,2891,003,7461,047,9621,050,065489,149490,709460,669476,030457,810471,157491,103493,730218,870219,720215,758208,012199,660575,728590,648
   > Total Current Liabilities 
264,702
280,221
189,126
188,885
196,272
201,483
201,765
244,374
252,111
242,437
239,451
230,168
226,843
268,973
279,566
373,573
415,094
414,497
433,726
412,702
435,058
464,612
457,915
446,436
461,717
459,426
459,426461,717446,436457,915464,612435,058412,702433,726414,497415,094373,573279,566268,973226,843230,168239,451242,437252,111244,374201,765201,483196,272188,885189,126280,221264,702
       Short-term Debt 
0
821
1,642
2,464
1,917
2,875
3,833
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000003,8332,8751,9172,4641,6428210
       Short Long Term Debt 
0
821
1,642
2,464
1,917
2,875
3,833
46,859
47,069
47,281
47,495
47,705
47,919
48,135
48,353
100,000
120,833
141,667
162,500
183,333
183,333
183,333
183,333
183,333
183,333
64,583
64,583183,333183,333183,333183,333183,333183,333162,500141,667120,833100,00048,35348,13547,91947,70547,49547,28147,06946,8593,8332,8751,9172,4641,6428210
       Accounts payable 
18,692
11,679
12,150
13,733
10,941
11,981
6,247
6,139
8,182
6,491
10,016
8,666
7,543
7,730
4,189
3,851
6,627
7,637
3,494
2,992
2,420
3,653
8,692
6,020
2,412
3,142
3,1422,4126,0208,6923,6532,4202,9923,4947,6376,6273,8514,1897,7307,5438,66610,0166,4918,1826,1396,24711,98110,94113,73312,15011,67918,692
       Other Current Liabilities 
123,297
127,943
15,465
523
23,113
26,754
27,648
30,356
32,831
35,122
23,779
12,545
9,931
49,008
58,461
86,020
87,014
77,487
73,554
0
73,233
0
0
0
0
3,044
3,044000073,233073,55477,48787,01486,02058,46149,0089,93112,54523,77935,12232,83130,35627,64826,75423,11352315,465127,943123,297
   > Long-term Liabilities 
0
0
0
19,127
19,486
18,237
17,105
249,356
238,992
228,720
218,359
245,862
233,826
221,736
258,750
676,492
632,868
589,249
709,175
621,864
578,049
534,093
489,962
445,645
375,088
941,449
941,449375,088445,645489,962534,093578,049621,864709,175589,249632,868676,492258,750221,736233,826245,862218,359228,720238,992249,35617,10518,23719,48619,127000
       Capital Lease Obligations Min Short Term Debt
0
-821
-1,642
8,150
8,619
7,487
6,261
9,938
9,780
9,667
9,495
9,320
9,142
8,959
8,765
9,091
8,811
8,526
8,224
7,915
7,601
7,347
7,112
6,873
6,631
7,185
7,1856,6316,8737,1127,3477,6017,9158,2248,5268,8119,0918,7658,9599,1429,3209,4959,6679,7809,9386,2617,4878,6198,150-1,642-8210
       Long-term Liabilities Other 
0
0
0
10,091
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,096
4,09600000000000000000000010,091000
> Total Stockholder Equity
82,681
70,780
91,585
86,350
85,823
84,258
87,432
141,063
155,767
172,686
186,031
170,035
253,066
251,094
202,928
196,076
197,612
197,194
194,842
179,733
200,805
178,873
195,431
222,169
216,583
234,279
234,279216,583222,169195,431178,873200,805179,733194,842197,194197,612196,076202,928251,094253,066170,035186,031172,686155,767141,06387,43284,25885,82386,35091,58570,78082,681
   Common Stock
33
33
33
33
33
34
34
34
34
35
35
35
36
36
36
36
37
37
37
0
38
0
0
0
0
0
0000038037373736363636353535343434343333333333
   Retained Earnings Total Equity00000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000
   Capital Surplus 00000000000000000000000000
   Treasury Stock00000000000000000000000000
   Other Stockholders Equity 00000-3800000000000000000000



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue566,767
Cost of Revenue-240,598
Gross Profit326,169326,169
 
Operating Income (+$)
Gross Profit326,169
Operating Expense-399,806
Operating Income166,961-73,637
 
Operating Expense (+$)
Research Development0
Selling General Administrative159,208
Selling And Marketing Expenses-
Operating Expense399,806159,208
 
Net Interest Income (+$)
Interest Income15,615
Interest Expense-83,339
Other Finance Cost-0
Net Interest Income-67,724
 
Pretax Income (+$)
Operating Income166,961
Net Interest Income-67,724
Other Non-Operating Income Expenses-
Income Before Tax (EBT)75,733190,465
EBIT - interestExpense = -83,339
48,155
131,494
Interest Expense83,339
Earnings Before Interest and Taxes (EBIT)-159,072
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax75,733
Tax Provision-27,578
Net Income From Continuing Ops48,15548,155
Net Income48,155
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-23,50467,724
 

Technical Analysis of Collegium Pharmaceutical Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Collegium Pharmaceutical Inc. The general trend of Collegium Pharmaceutical Inc is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Collegium Pharmaceutical Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Collegium Pharmaceutical Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 30.40 < 32.20 < 32.80.

The bearish price targets are: 29.40 > 27.40 > 27.40.

Tweet this
Collegium Pharmaceutical Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Collegium Pharmaceutical Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Collegium Pharmaceutical Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Collegium Pharmaceutical Inc. The current macd is 0.03942823.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Collegium Pharmaceutical Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Collegium Pharmaceutical Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Collegium Pharmaceutical Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Collegium Pharmaceutical Inc Daily Moving Average Convergence/Divergence (MACD) ChartCollegium Pharmaceutical Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Collegium Pharmaceutical Inc. The current adx is 13.26.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Collegium Pharmaceutical Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Collegium Pharmaceutical Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Collegium Pharmaceutical Inc. The current sar is 32.60.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Collegium Pharmaceutical Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Collegium Pharmaceutical Inc. The current rsi is 44.02. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Collegium Pharmaceutical Inc Daily Relative Strength Index (RSI) ChartCollegium Pharmaceutical Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Collegium Pharmaceutical Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Collegium Pharmaceutical Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Collegium Pharmaceutical Inc Daily Stochastic Oscillator ChartCollegium Pharmaceutical Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Collegium Pharmaceutical Inc. The current cci is -146.13778706.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Collegium Pharmaceutical Inc Daily Commodity Channel Index (CCI) ChartCollegium Pharmaceutical Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Collegium Pharmaceutical Inc. The current cmo is -20.07363063.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Collegium Pharmaceutical Inc Daily Chande Momentum Oscillator (CMO) ChartCollegium Pharmaceutical Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Collegium Pharmaceutical Inc. The current willr is -92.85714286.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Collegium Pharmaceutical Inc Daily Williams %R ChartCollegium Pharmaceutical Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Collegium Pharmaceutical Inc. The current atr is 0.72180033.

Collegium Pharmaceutical Inc Daily Average True Range (ATR) ChartCollegium Pharmaceutical Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Collegium Pharmaceutical Inc. The current obv is 2,200.

Collegium Pharmaceutical Inc Daily On-Balance Volume (OBV) ChartCollegium Pharmaceutical Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Collegium Pharmaceutical Inc. The current mfi is 40.07.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Collegium Pharmaceutical Inc Daily Money Flow Index (MFI) ChartCollegium Pharmaceutical Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Collegium Pharmaceutical Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-17 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-18 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-19 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-26 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-27 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-01 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-02 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-04 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-07 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-09 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-10 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-14 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-15 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-17 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-25 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-28 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-05 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-22 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-28 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-03 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-05 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-06 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-09 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-27 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-02 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-06 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-07 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-08 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-09 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-24 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-27 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-01-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-30 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-31 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-03 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-04 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-05 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Collegium Pharmaceutical Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Collegium Pharmaceutical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.018
Ma 20Greater thanMa 5031.400
Ma 50Greater thanMa 10029.872
Ma 100Greater thanMa 20031.322
OpenGreater thanClose29.600
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Collegium Pharmaceutical Inc with someone you think should read this too:
  • Are you bullish or bearish on Collegium Pharmaceutical Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Collegium Pharmaceutical Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Collegium Pharmaceutical Inc

I send you an email if I find something interesting about Collegium Pharmaceutical Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Collegium Pharmaceutical Inc.

Receive notifications about Collegium Pharmaceutical Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.